Key Quantitative Figures
- Total Amount Raised: ₹29.99 crores (raised on June 4, 2024).
- Object 1 - Capex (Jammu & Kashmir):
- Original Allocation: ₹2,249.99 lakh
- Modified Allocation: ₹599.99 lakh
- Funds Utilized: ₹536.40 lakh
- Deviation/Variation: ₹0.00
- Object 2 - General Corporate Purpose:
- Original Allocation: ₹750.00 lakh
- Modified Allocation: ₹0.00
- Funds Utilized: ₹749.50 lakh
- Deviation/Variation: ₹0.00
- Object 3 - Fund Infusion in Group Entity:
- Original Allocation: ₹0.00
- Modified Allocation: ₹1,650.00 lakh
- Funds Utilized: ₹112.50 lakh
- Deviation/Variation: ₹0.00
Parties Involved
- Issuer Company: JHS Svendgaard Laboratories Limited
- Group Entity: JHS Svendgaard Retail Ltd.
- Regulators Addressed: Bombay Stock Exchange Limited and National Stock Exchange of India Limited
Purpose/Rationale
The purpose of the fund infusion into JHS Svendgaard Retail Ltd. is stated as "funding the expansion through strategic fund infusion."
Financial Impact & Deviation Status
The company has reported NO deviation or variation in the use of funds for the quarter. The utilization is in line with the allocations, which were modified and approved by shareholders. The audit committee and auditors have provided no comments (NIL).
Capital Structure Impact
This is a report on the utilization of funds already raised and does not announce a new capital structure change.
Effective Date
The reported information is effective for the quarter ended March 31, 2026. The board approved the statement on May 26, 2026.